# Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?

> **NCT02562053** · PHASE3 · UNKNOWN · sponsor: **Cairo University** · enrollment: 300 (estimated)

## Conditions studied

- Premenstrual Syndrome

## Interventions

- **DRUG:** Fluoxetine
- **DRUG:** Combined oral contraceptives
- **DRUG:** Placebo 1
- **DRUG:** Placebo 2

## Key facts

- **NCT ID:** NCT02562053
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2016-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02562053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02562053, "Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02562053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*